MRK - Merck & Co., Inc.
About Merck & Co., Inc. (https://www.merck.com)
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Robert Davis | Chairman, President & Chief Executive Officer | 1967 | $4,629,860 USD |
| Dean Y. Li | Executive Vice President & President of Merck Research Laboratories | 1963 | $2,997,187 USD |
| Caroline Litchfield | Executive Vice President & Chief Financial Officer | 1969 | $2,400,632 USD |
| Betty D. Larson | Executive Vice President & Chief Human Resources Officer | 1976 | $2,294,965 USD |
| Jennifer L. Zachary | Executive Vice President & General Counsel | 1978 | $2,170,688 USD |
| Richard R. DeLuca Jr. | Executive Vice President & President of Merck Animal Health | 1963 | $2,169,938 USD |
| Sanat Chattopadhyay | Executive Vice President & President of Merck Manufacturing Division | 1960 | $2,094,079 USD |
| Chirfi Guindo | Executive Vice President of Strategic Access, Policy & Communications | 1966 | $1,541,708 USD |
| Dalton E. Smart | Senior Vice President of Finance, Principal Accounting Officer & Global Controller | 1967 | – |
| David Michael Williams | Executive Vice President and Chief Information & Digital Officer | 1969 | – |
| Eliav Barr | Chief Medical Officer & Head of Global Clinical Development of Merck Research Laboratories | 1965 | – |
| Eric H. Rubin | Senior Vice President of Global Clinical Oncology & Early-stage Oncology | 1960 | – |
| Joerg Koglin | Senior VP & Head of General Medicine - Global Clinical Development | – | – |
| Johannes J. Oosthuizen | Executive VP and President of Oncology & MSD International | 1968 | – |
| Peter Dannenbaum | Vice President of Investor Relations | – | – |